Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of COLL will rise by +9.64% over the next 2 Weeks and hit $31.92 by Thursday, August 20, 2026. In that time frame, COLL's share price is expected to range between $30.57 and $33.22.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Aug 20, 2026 | 30.57 | 31.92 | 33.22 |
| Aug 19, 2026 | 31.44 | 32.73 | 34.02 |
| Aug 18, 2026 | 31.04 | 32.29 | 33.60 |
| Aug 17, 2026 | 30.82 | 32.13 | 33.59 |
| Aug 14, 2026 | 31.03 | 32.31 | 33.62 |
| Aug 13, 2026 | 30.71 | 31.97 | 33.31 |
| Aug 12, 2026 | 31.48 | 32.78 | 34.03 |
| Aug 11, 2026 | 30.98 | 32.34 | 33.53 |
| Aug 10, 2026 | 30.98 | 32.18 | 33.32 |
| Aug 7, 2026 | 31.11 | 32.36 | 33.62 |
COLL shares fell -1.00% in Friday, August 7, 2026's trading session, dropping from a previous close of $29.11 to move at $28.82. The stock demonstrated notable intraday movement (see COLL's key stats for a full breakdown), fluctuating between $28.02 and $29.64, a +5.78% trading range. While recent weeks have seen some volatility, COLL has managed to secure a -18.13% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 2.13M shares changing hands, 1.73M more than the previous session. This amounted to $61.43M in total market activity.
Will COLL Continue Its Upward Trend?
According to analyst ratings and projections for COLL, Collegium Pharmaceutical, Inc. shares are anticipated to increase by +13.24%, potentially reaching $33.22 per share by August 20, 2026. Short-term technical indicators currently suggest a neutral sentiment for COLL. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 14 positive trading days within the past 30 sessions. Based on the COLL stock forecast, now is a good time to buy COLL stock because its current trading price is -9.70% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on COLL covering social and institutional perspectives.
COLL Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into COLL's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 16.15% to 30.23%) suggest the stock is experiencing strong bearish momentum. The 50-day RSI, at 40.27%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.41%, maintains a neutral outlook for the long term. Insights into COLL's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Collegium Pharmaceutical Short-Term Forecasts
COLL Forecast For Next 5 Days
Our algorithm anticipates Collegium Pharmaceutical (COLL) stock could hit $28.97 by Aug 14, 2026. This represents a +0.52% fall from today's price, following a -0.93% change over the past five days.
COLL Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Collegium Pharmaceutical, Inc. (COLL) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $28.72, which would mean a -0.35% decrease from the current price of $28.82. Projections for this period range from a high of $31.01 to a low of $26.35.
COLL Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Collegium Pharmaceutical's price over the next three months point to a rise. COLL stock is expected to peak at $39.45 on Nov 05, 2026 after potentially dipping to $30.66 on Aug 07, 2026. On average, COLL is likely to trade around $35.40 in the coming 90 days.
Collegium Pharmaceutical Stock Forecast 2025
Based on our predictive models, Collegium Pharmaceutical (COLL) is expected to trade between $30.66 and $42.21 throughout 2026. This would result in an average price of $35.67, potentially offering investors a +23.77% return from current levels.
Collegium Pharmaceutical, Inc. Monthly Forecast 2026–2027
August 2026
According to our latest forecast models, Collegium Pharmaceutical, Inc. (COLL) is positioned to show a strong performance in August 2026. The price is predicted to move between $30.66 and $36.89, settling at an average of $33.79. This could translate to a +17.33% gain.
September 2026
Based on current market signals, Collegium Pharmaceutical, Inc. is projected to trend september 2026. We forecast a trading range from $32.31 to $38.44, with a likely average price of $35.63. Investors could expect a potential return of +23.72%.
October 2026
Our predictive algorithms indicate Collegium Pharmaceutical, Inc. stock may see a shift in October 2026. The expected range spans $33.45–$38.77, with an average target of $36.13. This represents a positive outlook and a possible gain of +25.45%.
November 2026
Analyzing established trends, Collegium Pharmaceutical, Inc. looks set to move in November 2026. Projections place the stock between $34.10 and $42.21, averaging around $36.89. This suggests a +28.09% gain from current levels.
December 2026
Market indicators suggest Collegium Pharmaceutical, Inc. could experience notable changes during December 2026. Prices could fluctuate within $32.07 to $38.58, with a midpoint forecast of $35.54. The stock might deliver a +23.40% gain.
January 2027
Forecasting for January 2027, models estimate that Collegium Pharmaceutical, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $32.12 and $38.49, averaging $35.51. This signals a positive trajectory with potential returns around +23.30%.
February 2027
According to our latest forecast models, Collegium Pharmaceutical, Inc. (COLL) is positioned to show a strong performance in February 2027. The price is predicted to move between $34.79 and $39.97, settling at an average of $37.57. This could translate to a +30.45% gain.
March 2027
Based on current market signals, Collegium Pharmaceutical, Inc. is projected to trend march 2027. We forecast a trading range from $35.18 to $40.64, with a likely average price of $37.97. Investors could expect a potential return of +31.84%.
April 2027
Our predictive algorithms indicate Collegium Pharmaceutical, Inc. stock may see a shift in April 2027. The expected range spans $35.95–$41.00, with an average target of $38.52. This represents a positive outlook and a possible gain of +33.75%.
May 2027
Analyzing established trends, Collegium Pharmaceutical, Inc. looks set to move in May 2027. Projections place the stock between $34.34 and $40.38, averaging around $37.31. This suggests a +29.55% gain from current levels.
June 2027
Market indicators suggest Collegium Pharmaceutical, Inc. could experience notable changes during June 2027. Prices could fluctuate within $33.99 to $40.52, with a midpoint forecast of $37.39. The stock might deliver a +29.83% gain.
July 2027
Forecasting for July 2027, models estimate that Collegium Pharmaceutical, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $36.48 and $42.28, averaging $39.53. This signals a positive trajectory with potential returns around +37.26%.
August 2027
According to our latest forecast models, Collegium Pharmaceutical, Inc. (COLL) is positioned to show a strong performance in August 2027. The price is predicted to move between $37.87 and $42.55, settling at an average of $40.06. This could translate to a +39.10% gain.
COLL's history of dividends and stock splits also plays a role in long-term investor confidence.